Products & Pipeline

Cancer profiling and monitoring products

ArcherDX delivers cutting-edge turn-key molecular diagnostic products to laboratories and clinicians seeking better genomic answers to treat patients with cancer.

We use our patented technology – Anchored Multiplex PCR (AMP™) – to turn tissue and liquid biopsies into actionable genomic results for precision oncology selection and cancer monitoring.

We offer a suite of products and services that are highly accurate, personal, actionable and easy-to-use in local settings. This empowers clinicians to control the sample, data, patient care and economics.

Our products include

Solid Tumor Research Assays

Archer® Solid Tumor research assays provide a robust targeted sequencing approach to detect critical biomarkers from both liquid and tissue biopsies.

Deep molecular profiling of blood cancers

Archer® Blood Cancer research assays detect various driver mutations in hematologic malignancies, such as myeloid and lymphoid diseases, by targeted next-generation sequencing (NGS). This approach combines FusionPlex® and VariantPlex® panels to characterize gene fusions, point mutations, copy number variations (CNVs) and other variant types from a single sample.

Our Blood Cancer Research Assays

FusionPlex® RNA Tests

VariantPlex® DNA Tests

Key Features
Unified Workflow

All Archer panels are powered by Anchored Multiplex PCR (AMP™) chemistry and thus follow the same workflow for maximum lab efficiency.

Comprehensive Tumor Profiling

Get the most information from your sample - fusions, CNVs, SNVs, indels and expression levels.

Complex Variant Detection

Coverage combined with powerful bioinformatics enable variant detection of traditionally difficult regions like CEBPA & FLT3.

Confident Variant Calling

Powerful bioinformatics combined with orthogonal variant verification.

Solid Tumor Research Assays

Archer® Solid Tumor research assays provide a robust targeted sequencing approach to detect critical biomarkers from both liquid and tissue biopsies.

Deep molecular profiling of blood cancers

Archer® Blood Cancer research assays detect various driver mutations in hematologic malignancies, such as myeloid and lymphoid diseases, by targeted next-generation sequencing (NGS). This approach combines FusionPlex® and VariantPlex® panels to characterize gene fusions, point mutations, copy number variations (CNVs) and other variant types from a single sample.

Our Blood Cancer Research Assays

FusionPlex® RNA Tests

VariantPlex® DNA Tests

Key Features
Unified Workflow

All Archer panels are powered by Anchored Multiplex PCR (AMP™) chemistry and thus follow the same workflow for maximum lab efficiency.

Comprehensive Tumor Profiling

Get the most information from your sample - fusions, CNVs, SNVs, indels and expression levels.

Complex Variant Detection

Coverage combined with powerful bioinformatics enable variant detection of traditionally difficult regions like CEBPA & FLT3.

Confident Variant Calling

Powerful bioinformatics combined with orthogonal variant verification.

menu home-icon-silhouette remove-button twitter linkedin-1 facebook-circular-logo right